Economy

Maverick Capital Ltd. Buys Shares of 23580 IDEXX Laboratories, Inc. (IDXX)

Maverick Capital Ltd. Buys Shares of 23580 IDEXX Laboratories, Inc. (IDXX)”

The original version of this news story can be accessed at https://www.truebluetribune.com/2017/10/06/mutual-of-america-capital-management-llc-sells-670-shares-of-idexx-laboratories-inc-idxx.html. The institutional investor bought 23,580 shares of the company's stock, valued at approximately $3,806,000. Idex Laboratories now has $13.80 billion valuation. Rothschild Asset Mngmt invested in 9,104 shares or 0.01% of the stock.

Here is a rundown on some insider market activity for IDEXX Laboratories, Inc. Bank of America Corp (NYSE:BAC) has risen 58.64% since October 3, 2016 and is uptrending. It has outperformed by 66.60% the S&P500. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Based on the stock's volatility for the week, which is a statistical measure of the dispersion of returns for a given stock and represents average daily high/low percentage range of 1.57% and month of 2.05%. For the last quarter, the stock has performed -1.35%. The stock will be uptrending if it is being traded above its moving averages and downtrending if it is being traded below. It has underperformed by 11.76% the S&P500.

Fred Alger Management Inc. trimmed its holdings in IDEXX Laboratories, Inc. Credit Suisse maintained the shares of IDXX in report on Wednesday, April 13 with "Outperform" rating. During the same period in the previous year, the company earned $0.74 EPS. IDXX's profit will be $65.46M for 52.70 P/E if the $0.75 EPS becomes a reality.

Congress Asset Management Company decreased Cme Group Inc (CME) stake by 2.22% reported in 2017Q2 SEC filing.

Among 9 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 5 have Buy rating, 2 Sell and 2 Hold. Therefore 56% are positive.

IDXX has been the subject of several recent analyst reports. Cibc has invested 0.01% of its portfolio in IDEXX Laboratories, Inc.

02/01/2016 - IDEXX Laboratories, Inc. had its "neutral" rating reiterated by analysts at Piper Jaffray. (NASDAQ:IDXX) on Wednesday, July 20 with "Buy" rating. The firm has "Buy" rating by Stifel Nicolaus given on Thursday, October 29. The firm has "Buy" rating by Stifel Nicolaus given on Thursday, August 13. The rating was downgraded by Raymond James on Friday, August 28 to "Market Perform". (NASDAQ:IDXX) on Thursday, July 23 with "Buy" rating. Canaccord Genuity has "Buy" rating and $18000 target. The firm has "Buy" rating given on Tuesday, June 13 by Canaccord Genuity. On Friday, July 28 the stock rating was upgraded by C.L. King to "Buy". As per Friday, July 24, the company rating was upgraded by Feltl & Co. Canaccord Genuity maintained the shares of IDXX in report on Monday, August 21 with "Buy" rating. Its up 0.25, from 0.94 in 2017Q1.

Several other institutional investors also recently bought and sold shares of IDXX. 86 funds opened positions while 167 raised stakes. Connable Office Inc stated it has 5,090 shares. Connecticut-based Virtus Advisers has invested 0.03% in IDEXX Laboratories, Inc. IDEXX Laboratories reported sales of $448.31 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 10.1%. (NASDAQ:IDXX) traded up 0.73% during trading on Friday, hitting $159.27. Fundsmith Llp reported 7.53% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Rmb Mgmt Ltd Llc stated it has 36,321 shares or 0.17% of all its holdings. Menta Cap Limited Liability has invested 0.22% in IDEXX Laboratories, Inc. Aperio Gru Llc owns 0.05% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 1,917 shares. Peloton Wealth Strategists invested 2.07% of its portfolio in IDEXX Laboratories, Inc. Southeast Asset Advisors Inc.'s holdings in IDEXX Laboratories were worth $261,000 at the end of the most recent quarter. (NASDAQ:IDXX). Wells Fargo And Mn invested 0.02% in IDEXX Laboratories, Inc. Envestnet Asset Management has invested 0% in Oasis Petroleum Inc.

Investors are more bearish on IDEXX Laboratories, Inc. lately as indicated by the uptick in short interest. "(IDXX)" was first published by TrueBlueTribune and is owned by of TrueBlueTribune. (CJPXX) stake by 71,784 shares to 151,148 valued at $13.82 million in 2017Q2. State Street Corp raised its stake in shares of IDEXX Laboratories by 38.6% during the first quarter. Raytheon Co Com New (NYSE:RTN) was reduced too. The insider AYERS JONATHAN W sold $4.18M. The shares were sold at an average price of $155.22, for a total value of $2,793,960.00. HENDERSON REBECCA M had sold 1,700 shares worth $271,912. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Credit Agricole S A now owns 26,978 shares of the company's stock worth $4,172,000 after purchasing an additional 6,075 shares in the last quarter. Therefore 96% are positive. On Monday, March 21 the stock rating was maintained by Stifel Nicolaus with "Buy". The firm has "Hold" rating given on Friday, August 25 by Robert W. Baird. RBC Capital Markets maintained the shares of CME in report on Monday, February 8 with "Underperform" rating.

The Piotroski F-Score is a scoring system between 1-9 that determines a firm's financial strength. Moving averages are considered to be lagging indicators that simply take the average price of a stock over a certain period of time. Deutsche Bank maintained the shares of CME in report on Friday, January 8 with "Buy" rating.

Investors sentiment decreased to 0.88 in Q2 2017. Its up 0.25, from 0.94 in 2017Q1. (NYSE:OAS). Citigroup reported 459,030 shares. 1,331 were accumulated by Tdam Usa Inc. Harding Loevner Lp holds 0% or 70 shares. Intrust Bancshares Na holds 4,996 shares or 0.28% of its portfolio. 2,967 are held by Caprock Group. Raymond James Service owns 5,977 shares. Lipe & Dalton invested 2.91% in Biogen Inc (NASDAQ:BIIB). Chicago Equity Prtnrs Ltd Com holds 0.76% or 175,270 shares in its portfolio.

Congress Asset Management Company increased Alexion Pharmaceuticals Inc (NASDAQ:ALXN) stake by 5,614 shares to 37,502 valued at $4.56 million in 2017Q2.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Like this

loading...
loading...

Latest


07 October 2017
US approves possible $15 bln sale of THAAD missiles to Saudi Arabia
The blacklist also named the Houthi rebel group - also shamed past year - as being responsible for the killing or maiming of 414 children.

07 October 2017
Gold Prices Hit Fresh 2-Month Lows as Dollar Strengthens
Spot gold may slide to $1,260 per ounce as it has broken a support at $1,270, according to Reuters technicals analyst Wang Tao . Higher interest rates typically boost the dollar and aid bond yields, adding pressure on dollar-denominated, non-yielding gold.

07 October 2017
Comedian Ralphie May Has Passed Away
May and his wife, Lahna Turner, separated in 2015 after 10 years of marriage. "Ralphie" May died of cardiac arrest in Las Vegas, PEOPLE confirms.

07 October 2017
Sheriff's Office: 40 pounds of marijuana, firearms seized from Orange County home
The Orange County sheriff's office makes a big drug and weapons bust in a home about a mile north of Lake of the Woods. The sheriff's office K-9, and a K-9 from the Mebane police were used to help search the auto .

07 October 2017
Analyst Recommendations And Earnings Forecast: Paychex, Inc. (PAYX), Achaogen, Inc. (AKAO)
They now have a $62.00 price objective on the business services provider's stock, up from their prior price objective of $60.00. The business services provider reported $0.62 EPS for the quarter, beating analysts' consensus estimates of $0.60 by $0.02.

07 October 2017
Wall Street Consensus Watch on Innophos Holdings, Inc. (NASDAQ:IPHS)
The sales growth rate for a stock is a measure of how the stock's sales per share (SPS) has grown over a specific period of time. Principal Financial Group Inc. lifted its stake in PNC Financial Services Group, Inc. (The) in a research note on Wednesday.

07 October 2017
Trump's Access Hollywood tape played on repeat outside White House
At noon today , UltraViolet plans to host a peaceful rally at Lafayette Square Park called the "Rally to Grab Back". The screening began at 9 a.m. local time on Friday morning, and is set to end at 9 p.m.

07 October 2017
Aptevo Therapeutics Inc. (APVO) Coverage Initiated by Analysts at Piper Jaffray Companies
Investors are feeling more bullish on shares of Aptevo Therapeutics Inc . recently if you evaluate the decrease in short interest. Legal & General Group Plc grew its stake in shares of Aptevo Therapeutics by 11,751.3% in the second quarter.

07 October 2017
ValuEngine Lowers Boyd Gaming Corporation (BYD) to Hold
The company's shares were given away at $26.71 per share worth to an income of some $186,970 on account of Boyd William R. For BYD, the company now has $184.6 Million of cash on the books, which is offset by $23.99 Million current liabilities.

07 October 2017
Valuation Review: Anglogold Ashanti Ltd (AU) and Pier 1 Imports (PIR)
Finally, ValuEngine raised Pier 1 Imports from a "hold" rating to a "buy" rating in a report on Friday, September 15th. Any way you dice it, a dip below $4.06 a share would be very bad news for PIR's technical picture in the near-term.